Navigation Links
Aesthera Announces Breakthrough Innovations at 2009 American Academy of Dermatology (AAD) Meeting
Date:3/5/2009

AAD Launches include New Technologies, Innovative Applications and New Clinical Data

SAN FRANCISCO, March 5 /PRNewswire/ -- Aesthera today announced several new launches at the upcoming 67th annual meeting of the American Academy of Dermatology in San Francisco, CA. Aligned with the company's strategic imperative to stay at the forefront of innovations in skin management, the launches will focus on the company reinforcing its leadership as the premier device based solution for acne as well as the development and commercialization of innovative technological solutions for high demand patient procedures.

Strengthening Position as Leading Acne Treatment

Strengthening its leadership position as a premier treatment in the battle against acne, Aesthera announced its latest peer reviewed clinical paper titled "Treatment of Acne with Photopneumatic Therapy," by Tina S. Alster MD et al which is published in the March 2009 issue of the Journal of Drugs and Dermatology. The paper studies the clinical efficacy of Photopneumatic Therapy for the treatment of mild to severe facial acne. "Our study noted greatest improvement in patients with severe acne. We are pleased with treatment outcomes, especially for severe acne," said study co-investigator Dr. Alster. The study was performed using Aesthera's ISOLAZ system, the only FDA cleared device for the treatment of Comedonal and Pustular Acne.

Profusion Skin Therapy for Acne, Skin Rejuvenation and Body Tightening

Aesthera will launch Profusion(TM) - (Pro=Professional and Fusion=Combination) - a breakthrough skin therapy that combines the proven clinical benefits of Photopneumatic light treatments with the delivery of Aesthera's proprietary skincare to symbiotically enhance skin treatment outcomes for acne, skin rejuvenation and body tightening. "Profusion's novel mechanism has tremendous therapeutic potential for innovative new applications. We are very excited about its clinical potential," says Vic Narurkar, MD, Chair of Dermatology at the California Pacific Medical Center (CPMC) in San Francisco, CA. "Profusion Skin Therapy is the fastest growing procedure in our practice. We routinely perform it in combination with the majority of skin treatments we offer," he adds. New applications of the technology include body tightening and skin lightening.

Additionally, Aesthera will release results of a multi-year scientific collaboration with the University of California at Riverside on Profusion Skin Therapy. "Our collaboration with the UC Riverside team reflects our commitment to basing all our treatment solutions on solid science," says Robert Anderson, PhD, Co-Founder and Chief Technical Officer of Aesthera. "We are very excited about expanding the commercial applications of Profusion Skin Therapy and are working on future applications of this novel technology," he added.

Innovative Body Tightening Technology

Moving beyond existing frameworks that address and treat body tightening, shaping and contouring Aesthera will be previewing a revolutionary approach to body tightening technology. The company's innovative body tightening platform (pending FDA clearance) will utilize a unique delivery mechanism and state of the art applicator that allows for high treatment precision and focused energy delivery. The patient benefits of Aesthera's unique solution will be fast, painless, and extremely precise treatments.

"Our continuous development and commercialization of solutions reflects our commitment to growing and strengthening our leadership position in the dermatology market," said Alon Maor, Aesthera's President & CEO.

In addition, to the above launches, Aesthera's technology will be included in over 11 podium presentations by thought leaders in dermatology.

For a complete list of podium presentations, or for more information on Profusion Skin Therapy or Isolaz Light Treatments, visit www.AESTHERA.Com, www.ISOLAZ.com, call 877.275.4779, or email WeListen@AESTHERA.com.

About Photopneumatic(TM) Technology

Photopneumatic Therapy, that powers the Isolaz(TM) and Isolaz Pro(TM) system, is a proprietary combination of pneumatic energy and broad band light. Photopneumatic devices are the only laser or light based devices cleared for the treatment of inflammatory acne, comedonal acne and pustular acne. They are also cleared for the treatment of mild to moderate inflammatory acne. Photopneumatic treatments have an immediate visible impact on acne 24 - 48 hour post first treatment and are painless. Facial treatments take approximately 10 minutes, require no anesthetics or numbing creams and provide additional cosmetic benefits such as smoother appearing skin. Additionally, Photopneumatic treatments have an immediate visible impact on acne 24 - 48 hour post first treatment and are painless. Facial treatments take approximately 10 minutes, require no anesthetics or numbing creams and provide additional cosmetic benefits such as smoother appearing skin. Additionally, Photopneumatic Therapy is also cleared for the treatment of benign vascular and pigmented lesions and hair removal.

About Aesthera Corporation

Aesthera (www.AESTHERA.com) develops, manufactures and markets light-based aesthetic treatment systems - the Isolaz(TM) and Isolaz Pro(TM) platforms - based on proprietary Photopneumatic(TM) technology. Clinically proven to be pain-free and up to seven times faster than currently available light-based aesthetic systems, Aesthera's revolutionary systems combine the proven properties of therapeutic light with gentle pneumatic energy to more effectively work on dermal and epidermal skin targets.

    Contact:
    Sarvar Kothavala
    Aesthera Corp.
    415.760.0902
    SKothavala@Aesthera.com


'/>"/>
SOURCE Aesthera Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... On Tuesday, April 26, ... the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, the “Rural ... (R - Cumming), offers a 70% tax credit to individuals and corporations which donate ...
(Date:4/29/2016)... Fort Stewart, GA (PRWEB) , ... April 29, 2016 , ... ... on Monday, May 16, 2016, at its new location in the Exchange Furniture Mall ... including a raffle for a 50-inch Samsung Smart TV. Plus attendees will have the ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... announces the Gyrociser, an exercise invention which aids in proper muscle development. , ... Cooper, CEO and Creative Director of World Patent Marketing. "Globalization has threatened the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Reltok Nasal Products proudly announces that Boston Medical ... neck/ear, nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to its diverse ... is a newly patented safety device secured by nasal surgeons onto the floor of ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... print media enterprise focused entirely on patients with cancer, today announced that Lynne ... chosen as the 2016 CURE® Extraordinary Healer® for Oncology Nursing , which ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... 29, 2016 ReportsnReports.com adds ... market research report that provides an overview of ... at various stages, therapeutics assessment by drug target, ... and molecule type, along with latest updates, and ... key players involved in the therapeutic development for ...
(Date:4/29/2016)... , April 29, 2016 ... glyco-biology expertise, today announces the appointment of Dr. ... Dr. Zurlo is an oncologist with many years clinical ... and biotechnology industries. His last role was at Mologen ... of the Executive Board. Previously Dr. Zurlo held various ...
(Date:4/28/2016)... 28, 2016  While Abbott,s announced purchase of ... valve repair and stent business, healthcare research firm ... more firmly into patient monitoring.  Kalorama said that ... device areas, with double-digit growth expected the next ... Advanced Remote Patient Monitoring . Abbott Laboratories ...
Breaking Medicine Technology: